Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$18.8 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 532.09M 418.28M 124.38M 80.86M
Cost of Sales 4.27M 5.87M 4.37M 6.12M
Gross Operating Profit 527.82M 412.41M 120.01M 74.74M
Selling, General, and Administrative Expenses 249.87M 160.31M 72.25M 59.17M
Research & Development 66.08M 42.88M 24.16M 20.56M
Operating Income before D & A (EBITDA) 211.86M 209.22M 23.60M -4.99M
Depreciation & Amortization 112.61M 82.63M 15.93M 5.84M
Interest Income 3.15M 1.51M 975.00K 1.05M
Other Income - Net 189.00K -30.87M -9.26M 964.00K
Special Income / Charges -19.66M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 82.21M 93.09M -2.65M -9.60M
Interest Expense 73.15M 53.25M 14.70M 0.00
Pre-Tax Income 9.05M 39.84M -17.34M -9.60M
Income Taxes 11.54M 7.07M -153.16M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -2.48M 32.78M 135.82M -9.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -2.48M 32.78M 135.82M -9.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -2.48M 32.78M 135.82M -9.60M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
17.89M 36.91M 137.84M -8.82M
Preferred Dividends
Net Income Available To Common -2.48M 32.78M 135.82M -9.60M
Basic EPS from Continuing Ops. -0.07 1.04 6.06 -0.44
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.07 1.04 6.06 -0.44
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.07 1.04 6.06 -0.44
Basic Normalized Net Income/Share 0.50 1.17 6.15 -0.40
EPS fr Continuing Ops. -0.07 0.93 5.45 -0.44
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.07 0.93 5.45 -0.44
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.07 0.93 5.45 -0.44
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.50 1.05 5.53 -0.40
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter